Cargando…
Discovery and characterization of small molecule Rac1 inhibitors
Aberrant activation of Rho GTPase Rac1 has been observed in various tumor types, including pancreatic cancer. Rac1 activates multiple signaling pathways that lead to uncontrolled proliferation, invasion and metastasis. Thus, inhibition of Rac1 activity is a viable therapeutic strategy for proliferat...
Autores principales: | Arnst, Jamie L., Hein, Ashley L., Taylor, Margaret A., Palermo, Nick Y., Contreras, Jacob I., Sonawane, Yogesh A., Wahl, Andrew O., Ouellette, Michel M., Natarajan, Amarnath, Yan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470993/ https://www.ncbi.nlm.nih.gov/pubmed/28410221 http://dx.doi.org/10.18632/oncotarget.16656 |
Ejemplares similares
-
Cyclin Dependent
Kinase 9 Inhibitors for Cancer Therapy: Miniperspective
por: Sonawane, Yogesh A., et al.
Publicado: (2016) -
RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment
por: Hein, Ashley L., et al.
Publicado: (2016) -
Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
por: Yan, Ying, et al.
Publicado: (2014) -
Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
por: Yan, Ying, et al.
Publicado: (2020) -
Rac1 GTPase in pancreatic cancer
por: Yan, Ying, et al.
Publicado: (2015)